Your heartHealthy livingFor professionalsResearchHow you can helpAbout us
Dr Matthew Burrage, 2023 Postdoctoral Fellowship

Novel diagnostic strategies for cardiac amyloidosis

Research directory


Novel diagnostic strategies for cardiac amyloidosis

Dr Matthew Burrage, The University of Queensland

Year 2023 Postdoctoral Fellowship

Years funded: 2024 - 2026

Cardiac amyloidosis is an increasingly common, yet life-threatening disease caused by abnormal protein build-up within the heart. Newly available treatments for cardiac amyloidosis have emphasised the importance of early diagnosis and management. Current non-invasive diagnostic tests (e.g., bone scans, MRI) are poorly suited for disease screening and monitoring as they are time-consuming and require radiation, radioactive tracers, or contrast agents (often not recommended in many patients). This research aims to further develop a “virtual contrast” artificial-intelligence-based MRI technology called Virtual Native Enhancement (VNE) as a fast, safe, cheap, radiation- and contrast-free tool for the diagnosis of cardiac amyloidosis. Analysis of heart biopsy samples and novel blood biomarkers, including immune cell signalling, aims to provide a tool to differentiate between the types of amyloidosis that can affect the heart.

Last updated12 March 2024